Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis.
Roy A, Brenneman RJ, Hogan J, Barnes JM, Huang Y, Morris R, Goddu S, Altman M, Garcia-Ramirez J, Li H, Zoberi JE, Bullock A, Kim E, Smith Z, Figenshau R, Andriole GL, Baumann BC, Michalski JM, Gay HA.
Roy A, et al. Among authors: barnes jm.
Clin Transl Radiat Oncol. 2021 May 13;29:47-53. doi: 10.1016/j.ctro.2021.05.004. eCollection 2021 Jul.
Clin Transl Radiat Oncol. 2021.
PMID: 34136665
Free PMC article.